BriaCell Therapeutics - Warrants (24/02/2025) Overview
BriaCell Therapeutics - Warrants (24/02/2025) Discounted Cash Flow
DCF Analysis for BCTXW.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.04
Current Fair Value
$0.04
↑ 3955.6% Upside
Undervalued by 3955.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison